|
1
|
Argiris A, Karamouzis MV, Raben D and
Ferris RL: Head and neck cancer. Lancet. 371:1695–1709. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
NCCN Clinical Practice Guidelines in
Oncology (NCCN Guidelines). Head and Neck Cancers. Version 1.2020.
National Comprehensive Cancer Network; Fort Washington: 2020
|
|
5
|
Li CC, Shen Z, Bavarian R, Yang F and
Bhattacharya A: Oral cancer: Genetics and the role of precision
medicine. Surg Oncol Clin N Am. 29:127–144. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reina-Campos M, Moscat J and Diaz-Meco M:
Metabolism shapes the tumor microenvironment. Curr Opin Cell Biol.
48:47–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brouty-Boyé D: Developmental biology of
fibroblasts and neoplastic disease. Prog Mol Subcell Biol.
40:55–77. 2005. View Article : Google Scholar
|
|
8
|
Kalluri R: The biology and function of
fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu W, Zaal EA, Berkers CR, Lemeer S and
Heck AJR: CTGF/VEGFA-activated fibroblasts promote tumor migration
through Micro-environmental modulation. Mol Cell Proteomics.
17:1502–1514. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abdul-Wahid A, Cydzik M, Fischer NW,
Prodeus A, Shively JE, Martel A, Alminawi S, Ghorab Z, Berinstein
NL and Gariépy J: Serum-derived carcinoembryonic antigen (CEA)
activates fibroblasts to induce a local re-modeling of the
extracellular matrix that favors the engraftment of CEA-expressing
tumor cells. Int J Cancer. 143:1963–1977. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu Y, Zhang L, Zha H, Yang F, Hu C, Chen
L, Guo B and Zhu B: Stroma-derived Fibrinogen-like protein 2
activates cancer-associated fibroblasts to promote tumor growth in
lung cancer. Int J Biol Sci. 13:804–814. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tao L, Huang G, Song H, Chen Y and Chen L:
Cancer associated fibroblasts: An essential role in the tumor
microenvironment. Oncol Lett. 14:2611–2620. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sharon Y, Alon L, Glanz S, Servais C and
Erez N: Isolation of normal and cancer-associated fibroblasts from
fresh tissues by Fluorescence Activated Cell Sorting (FACS). J Vis
Exp. e44252013.doi: 10.3791/4425. PubMed/NCBI
|
|
14
|
Ishii G, Ochiai A and Neri S: Phenotypic
and functional heterogeneity of cancer-associated fibroblast within
the tumor microenvironment. Adv Drug Deliv Rev. 99:186–196. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ziani L, Chouaib S and Thiery J:
Alteration of the antitumor immune response by cancer-associated
fibroblasts. Front Immunol. 9:4142018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kashima H, Noma K, Ohara T, Kato T,
Katsura Y, Komoto S, Sato H, Katsube R, Ninomiya T, Tazawa H, et
al: Cancer-associated fibroblasts (CAFs) promote the lymph node
metastasis of esophageal squamous cell carcinoma. Int J Cancer.
144:828–840. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huber L, Birk R, Rotter N, Aderhold C,
Lammert A, Jungbauer F and Kramer B: Effect of small-molecule
tyrosine kinase inhibitors on PDGF-AA/BB and PDGFRα/β expression in
SCC according to HPV16 Status. Anticancer Res. 40:825–835. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ouyang L, Zhang K, Chen J, Wang J and
Huang H: Roles of platelet-derived growth factor in vascular
calcification. J Cell Physiol. 233:2804–2814. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heldin CH, Lennartsson J and Westermark B:
Involvement of platelet-derived growth factor ligands and receptors
in tumorigenesis. J Intern Med. 283:16–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang D, Wang Y, Shi Z, Liu J, Sun P, Hou
X, Zhang J, Zhao S, Zhou BP and Mi J: Metabolic reprogramming of
cancer-associated fibroblasts by IDH3α downregulation. Cell Rep.
10:1335–1348. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maass PG, Luft FC and Bahring S: Long
non-coding RNA in health and disease. J Mol Med (Berl). 92:337–346.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang L, Wang G, Jia T, Zhang L, Li Y, Han
Y, Zhang K, Lin G, Zhang R, Li J and Wang L: Armored long
non-coding RNA MEG3 targeting EGFR based on recombinant MS2
bacteriophage virus-like particles against hepatocellular
carcinoma. Oncotarget. 7:23988–24004. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu M, Zhang C, Chen D, Chen S and Zheng
H: lncRNA MALAT1 potentiates the progression of tongue squamous
cell carcinoma through regulating miR-140-5p-PAK1 pathway. Onco
Targets Ther. 12:1365–1377. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kolenda T, Guglas K, Ryś M, Bogaczynska M,
Teresiak A, Bliźniak R, Łasińska I, Mackiewicz J and Lamperska KM:
Biological role of long non-coding RNA in head and neck cancers.
Rep Pract Oncol Radiother. 22:378–388. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ding L, Ren J, Zhang D, Li Y, Huang X, Hu
Q, Wang H, Song Y, Ni Y and Hou Y: A novel stromal lncRNA signature
reprograms fibroblasts to promote the growth of oral squamous cell
carcinoma via LncRNA-CAF/interleukin-33. Carcinogenesis.
39:397–406. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao L, Ji G, Le X, Wang C, Xu L, Feng M,
Zhang Y, Yang H, Xuan Y, Yang Y, et al: Long noncoding RNA
LINC00092 acts in cancer-associated fibroblasts to drive glycolysis
and progression of ovarian cancer. Cancer Res. 77:1369–1382. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Freitas R and Fraga CAM: NF-κB-IKKβ
pathway as a target for drug development: Realities, challenges and
perspectives. Curr Drug Targets. 19:1933–1942. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park MH and Hong JT: Roles of NF-kappaB in
cancer and inflammatory diseases and their therapeutic approaches.
Cells. 5:152016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu J, Chen S, Wang W, Ning BF, Chen F,
Shen W, Ding J, Chen W, Xie WF and Zhang X: Cancer-associated
fibroblasts promote hepatocellular carcinoma metastasis through
chemokine-activated hedgehog and TGF-β pathways. Cancer Lett.
379:49–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li X, Xu Q, Wu Y, Li J, Tang D, Han L and
Fan Q: A CCL2/ROS autoregulation loop is critical for
cancer-associated fibroblasts-enhanced tumor growth of oral
squamous cell carcinoma. Carcinogenesis. 35:1362–1370. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jing Z, Yuan X, Zhang J, Huang X, Zhang Z,
Liu J, Zhang M, Oyang J, Zhang Y, Zhang Z and Yang R: Chromosome 1
open reading frame 190 promotes activation of NF-κB canonical
pathway and resistance of dendritic cells to tumor-associated
inhibition in vitro. J Immunol. 185:6719–6727. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saini H, Rahmani Eliato K, Veldhuizen J,
Zare A, Allam M, Silva C, Kratz A, Truong D, Mouneimne G, LaBaer J,
et al: The role of tumor-stroma interactions on desmoplasia and
tumorigenicity within a microengineered 3D platform. Biomaterials.
247:1199752020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Faghihi MA and Wahlestedt C: Regulatory
roles of natural antisense transcripts. Nat Rev Mol Cell Biol.
10:637–643. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ørom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 1:46–58. 2010. View Article : Google Scholar
|
|
35
|
Cabili MN, Trapnell C, Goff L, Koziol M,
Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human
large intergenic noncoding RNAs reveals global properties and
specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fish JE, Santoro MM, Morton SU, Yu S, Yeh
RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY and Srivastava D:
miR-126 regulates angiogenic signaling and vascular integrity. Dev
Cell. 15:272–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang S, Zhu M, Wang Q, Hou Y, Li L, Weng
H, Zhao Y, Chen D, Ding H, Guo J and Li M: Alpha-fetoprotein
inhibits autophagy to promote malignant behaviour in hepatocellular
carcinoma cells by activating PI3K/AKT/mTOR signalling. Cell Death
Dis. 9:10272018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Olumi AF, Grossfeld GD, Hayward SW,
Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fibroblasts
direct tumor progression of initiated human prostatic epithelium.
Cancer Res. 59:5002–5011. 1999.PubMed/NCBI
|
|
40
|
Lu Y, Chen R, Ma JY, Wang LP, Qiu LL, Wang
CP, Yan JC and Liu PJ: Platelet derived growth factor-BB regulates
phenotype transformation of pulmonary artery smooth muscle cells
via SIRT3 affecting glycolytic pathway. Zhonghua Xin Xue Guan Bing
Za Zhi. 47:993–999. 2019.(In Chinese). PubMed/NCBI
|
|
41
|
Gialeli C, Nikitovic D, Kletsas D,
Theocharis AD, Tzanakakis GN and Karamanos NK: PDGF/PDGFR signaling
and targeting in cancer growth and progression: Focus on tumor
microenvironment and cancer-associated fibroblasts. Curr Pharm Des.
20:2843–2848. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Aoto K, Ito K and Aoki S: Complex
formation between platelet-derived growth factor receptor beta and
transforming growth factor beta receptor regulates the
differentiation of mesenchymal stem cells into cancer-associated
fibroblasts. Oncotarget. 9:34090–34102. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rizvi S, Mertens JC, Bronk SF, Hirsova P,
Dai H, Roberts LR, Kaufmann SH and Gores GJ: Platelet-derived
growth factor primes cancer-associated fibroblasts for apoptosis. J
Biol Chem. 289:22835–22849. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shiga K, Hara M, Nagasaki T, Sato T,
Takahashi H and Takeyama H: Cancer-associated fibroblasts: Their
characteristics and their roles in tumor growth. Cancers (Basel).
7:2443–2458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Primac I, Maquoi E, Blacher S, Heljasvaara
R, Van Deun J, Smeland HY, Canale A, Louis T, Stuhr L, Sounni NE,
et al: Stromal integrin α11 regulates PDGFR-β signaling and
promotes breast cancer progression. J Clin Invest. 129:4609–4628.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang S, Tao X, Cao Q, Feng X, Wu J, Yu H,
Yu Y, Xu C and Zhao H: lnc003875/miR-363/EGR1 regulatory network in
the carcinoma -associated fibroblasts controls the angiogenesis of
human placental site trophoblastic tumor (PSTT). Exp Cell Res.
387:1117832020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zheng B, Ohuchida K, Chijiiwa Y, Zhao M,
Mizuuchi Y, Cui L, Horioka K, Ohtsuka T, Mizumoto K, Oda Y, et al:
CD146 attenuation in cancer-associated fibroblasts promotes
pancreatic cancer progression. Mol Carcinog. 55:1560–1572. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yao Q, Qu X, Yang Q, Wei M and Kong B:
CLIC4 mediates TGF-beta1-induced fibroblast-to-myofibroblast
transdifferentiation in ovarian cancer. Oncol Rep. 22:541–548.
2009.PubMed/NCBI
|
|
49
|
Binns D, Dimmer E, Huntley R, Barrell D,
O'Donovan C and Apweiler R: QuickGO: a web-based tool for Gene
Ontology searching. Bioinformatics. 25:3045–3046. 2009. View Article : Google Scholar : PubMed/NCBI
|
